These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


64 related items for PubMed ID: 20853618

  • 1. [Participation of D(1)-receptors in anxiety-depression-like behaviour in female rats for ovary cycle].
    Fedotova IuO.
    Patol Fiziol Eksp Ter; 2010; (3):30-3. PubMed ID: 20853618
    [Abstract] [Full Text] [Related]

  • 2. [Behavioral effects of m-CPP and ketanserine during ovarian cycle in female rats].
    Fedotova IuO.
    Eksp Klin Farmakol; 2010 Nov; 73(11):6-9. PubMed ID: 21254590
    [Abstract] [Full Text] [Related]

  • 3. [D2-type dopaminergic receptors and anxiety-depression-like behavior in female rats].
    Fedotova IuO.
    Eksp Klin Farmakol; 2012 Nov; 75(2):3-6. PubMed ID: 22550850
    [Abstract] [Full Text] [Related]

  • 4. [Stimulation of D1-receptors improves passive avoidance learning of female rats during ovary cycle].
    Fedotova IuO, Sapronov NS.
    Eksp Klin Farmakol; 2012 Nov; 75(4):3-6. PubMed ID: 22702101
    [Abstract] [Full Text] [Related]

  • 5. [Participation of 5-HT2A/2C AND 5-HT2A/2C subtypes of serotonergic receptors in anxiety-depressive-like behaviur of females rats in key phases of ovary cycle].
    Fedotova IuO.
    Ross Fiziol Zh Im I M Sechenova; 2010 Apr; 96(4):426-32. PubMed ID: 20564963
    [Abstract] [Full Text] [Related]

  • 6. [D2-subtype of dopaminergic receptors is involved in anxiety behavior in ovariectomized rats].
    Fedotova IuO.
    Patol Fiziol Eksp Ter; 2008 Apr; (3):10-3. PubMed ID: 18942469
    [Abstract] [Full Text] [Related]

  • 7. [Involvement of some subtypes of 5-HT2-receptors in affective behavior in female rats].
    Fedotova IuO, Ordian NE, Frolova HO, Soboliev VI.
    Fiziol Zh (1994); 2012 Apr; 58(6):75-80. PubMed ID: 23530416
    [Abstract] [Full Text] [Related]

  • 8. Effects of SKF-38393, a dopamine D1 receptor agonist on expression of amphetamine-induced behavioral sensitization and expression of immediate early gene arc in prefrontal cortex of rats.
    Moro H, Sato H, Ida I, Oshima A, Sakurai N, Shihara N, Horikawa Y, Mikuni M.
    Pharmacol Biochem Behav; 2007 May; 87(1):56-64. PubMed ID: 17499349
    [Abstract] [Full Text] [Related]

  • 9. The atypical dopamine D1 receptor agonist SKF 83959 induces striatal Fos expression in rats.
    Wirtshafter D, Osborn CV.
    Eur J Pharmacol; 2005 Dec 28; 528(1-3):88-94. PubMed ID: 16324697
    [Abstract] [Full Text] [Related]

  • 10. Agonist efficacy and the behavioral effects of dopamine D1 receptor ligands: drug interaction studies in squirrel monkeys.
    Bergman J, Spealman RD, Madras BK, Rosenzweig-Lipson S.
    J Pharmacol Exp Ther; 1996 Mar 28; 276(3):942-50. PubMed ID: 8786574
    [Abstract] [Full Text] [Related]

  • 11. Comparison of the D1-dopamine agonists SKF-38393 and A-68930 in neonatal 6-hydroxydopamine-lesioned rats: behavioral effects and induction of c-fos-like immunoreactivity.
    Johnson KB, Criswell HE, Jensen KF, Simson PE, Mueller RA, Breese GR.
    J Pharmacol Exp Ther; 1992 Aug 28; 262(2):855-65. PubMed ID: 1354257
    [Abstract] [Full Text] [Related]

  • 12. Involvement of D1 receptors in depression-like behavior of ovariectomized rats.
    Fedotova J, Ordyan N.
    Acta Physiol Hung; 2011 Jun 28; 98(2):165-76. PubMed ID: 21616775
    [Abstract] [Full Text] [Related]

  • 13. [Effects of 5-HT1 and 5-HT2 serotonin receptors on anxiety- and depression-like behavior in female rats].
    Fedotova IuO.
    Eksp Klin Farmakol; 2011 Jun 28; 74(3):6-9. PubMed ID: 21598629
    [Abstract] [Full Text] [Related]

  • 14. D(1)-like receptor activation improves PCP-induced cognitive deficits in animal models: Implications for mechanisms of improved cognitive function in schizophrenia.
    McLean SL, Idris NF, Woolley ML, Neill JC.
    Eur Neuropsychopharmacol; 2009 Jun 28; 19(6):440-50. PubMed ID: 19268547
    [Abstract] [Full Text] [Related]

  • 15. Infralimbic D1 receptor agonist effects on spontaneous novelty exploration and anxiety-like defensive responding in CD-1 mice.
    Wall PM, Blanchard RJ, Markham C, Yang M, Blanchard DC.
    Behav Brain Res; 2004 Jun 04; 152(1):67-79. PubMed ID: 15135970
    [Abstract] [Full Text] [Related]

  • 16. Modulation of heroin and cocaine self-administration by dopamine D1- and D2-like receptor agonists in rhesus monkeys.
    Rowlett JK, Platt DM, Yao WD, Spealman RD.
    J Pharmacol Exp Ther; 2007 Jun 04; 321(3):1135-43. PubMed ID: 17351103
    [Abstract] [Full Text] [Related]

  • 17. Super-stereotypy I: enhancement of a complex movement sequence by systemic dopamine D1 agonists.
    Berridge KC, Aldridge JW.
    Synapse; 2000 Sep 01; 37(3):194-204. PubMed ID: 10881041
    [Abstract] [Full Text] [Related]

  • 18. Dopamine D1-like receptors agonist SKF 38393 increases cFOS expression in the paraventricular nucleus of the hypothalamus--impact of acute and chronic cocaine.
    Chocyk A, Czyrak A, Wedzony K.
    J Physiol Pharmacol; 2008 Sep 01; 59(3):425-40. PubMed ID: 18953088
    [Abstract] [Full Text] [Related]

  • 19. Topographical resolution of jaw movements mediated by cyclase- vs. non-cyclase-coupled dopamine D(1)-like receptors: studies with SK&F 83822.
    Fujita S, Lee J, Kiguchi M, Uchida T, Cools AR, Waddington JL, Koshikawa N.
    Eur J Pharmacol; 2006 May 24; 538(1-3):94-100. PubMed ID: 16682023
    [Abstract] [Full Text] [Related]

  • 20. Antidepressant-like effect of selective dopamine D1 receptor agonists in the behavioural despair animal model of depression.
    D'Aquila PS, Collu M, Pani L, Gessa GL, Serra G.
    Eur J Pharmacol; 1994 Sep 01; 262(1-2):107-11. PubMed ID: 7813561
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 4.